Finlande occidentale And NotJuliane Winkelmann
List of bibliographic references
Number of relevant bibliographic references: 26.Ident. | Authors (with country if any) | Title |
---|---|---|
000D49 | Juho Joutsa [Finlande] ; Kirsti Martikainen ; Solja Niemel ; Jarkko Johansson ; Sarita Forsback ; Juha O. Rinne ; Valtteri Kaasinen | Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders. |
001088 | Juho Joutsa [Finlande] ; Kirsti Martikainen [Finlande] ; Solja Niemel [Finlande] ; Jarkko Johansson [Finlande] ; Sarita Forsback [Finlande] ; Juha O. Rinne [Finlande] ; Valtteri Kaasinen [Finlande] | Increased Medial Orbitofrontal [18 F]fluorodopa Uptake in Parkinsonian Impulse Control Disorders |
001907 | Maja Kojovic [Royaume-Uni] ; Mikko Kuoppam Ki [Finlande] ; Niall Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | “Progressive delayed‐onset postanoxic dystonia” diagnosed with PANK2 mutations 26 years after onset—An update |
001A23 | M. K. Karvonen [Finlande] ; V. Kaasinen [Finlande] ; M. Korja [Finlande] ; R. J. Marttila [Finlande] | Ropinirole diminishes myoclonus and improves writing and postural balance in an ULD patient |
002481 | Anna Brück [Finlande] ; Sargo Aalto [Finlande] ; Elina Rauhala [Finlande] ; Jörgen Bergman [Finlande] ; Reijo Marttila [Finlande] ; Juha O. Rinne [Finlande] | A follow‐up study on 6‐[18F]fluoro‐L‐dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen |
002822 | Aki S. Havulinna [Finlande] ; Pentti J. Tienari [Finlande] ; Reijo J. Marttila [Finlande] ; Kirsti K. Martikainen [Finlande] ; Johan G. Eriksson [Finlande] ; Olli Taskinen [Finlande] ; Elena Moltchanova [Finlande] ; Marjatta Karvonen [Finlande] | Geographical variation of medicated parkinsonism in Finland during 1995 to 2000 |
002E95 | Chul Hyoung Lyoo [Corée du Sud] ; Sargo Aalto [Finlande] ; Juha O. Rinne [Finlande] ; Ki Ook Lee [Corée du Sud] ; Seung Hun Oh [Corée du Sud] ; Jin Woo Chang [Corée du Sud] ; Myung Sik Lee [Corée du Sud] | Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait |
003098 | CHUL HYOUNG LYOO [Corée du Sud] ; Sargo Aalto [Finlande] ; Juha O. Rinne [Finlande] ; KI OOK LEE [Corée du Sud] ; SEUNG HUN OH [Corée du Sud] ; JIN WOO CHANG [Corée du Sud] ; MYUNG SIK LEE [Corée du Sud] | Different Cerebral Cortical Areas Influence the Effect of Subthalamic Nucleus Stimulation on Parkinsonian Motor Deficits and Freezing of Gait |
003175 | Anna Brück [Finlande] ; Sargo Aalto [Finlande] ; Elina Nurmi [Finlande] ; Tero Vahlberg [Finlande] ; Jörgen Bergman [Finlande] ; Juha O. Rinne [Finlande] | Striatal subregional 6‐[18F]fluoro‐L‐dopa uptake in early Parkinson's disease: A two‐year follow‐up study |
003293 | Kirsti K. Martikainen [Finlande] ; Tiina H. Luukkaala [Finlande] ; Reijo J. Marttila [Finlande] | Parkinson's disease and working capacity |
003626 | Anna Brück [Finlande] ; Sargo Aalto [Finlande] ; Elina Nurmi [Finlande] ; Tero Vahlberg [Finlande] ; Jorgen Bergman [Finlande] ; Juha O. Rinne [Finlande] | Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease : A two-year follow-up study |
003C79 | Valtteri Kaasinen [Finlande] ; Sargo Aalto [Finlande] ; Kjell N Gren [Finlande] ; Juha O. Rinne [Finlande] | Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease |
003F77 | Katinka Tuisku [Finlande] ; Matti Mikael Holi [Finlande] ; Kristian Wahlbeck [Finlande] ; Aulikki Johanna Ahlgren [Finlande] ; Hannu Lauerma [Finlande] | Quantitative rest activity in ambulatory monitoring as a physiological marker of restless legs syndrome: A controlled study |
004085 | Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] | Fipamezole (JP‐1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease |
004706 | Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Merja Haaparanta [Finlande] ; Olof Solin [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande] | Rate of progression in Parkinson's disease: A 6‐[18F]fluoro‐L‐dopa PET study |
004939 | Anne-Maria Kuopio [Finlande] ; Reijo J. Marttila [Finlande] ; Hans Helenius [Finlande] ; Miikka Toivonen [Finlande] ; Urpo K. Rinne [Finlande] | The quality of life in Parkinson's disease |
004D53 | Anne-Maria Kuopio [Finlande] ; Reijo J. Marttila [Finlande] ; Hans Helenius [Finlande] ; Urpo K. Rinne [Finlande] | Environmental risk factors in Parkinson's disease |
005D54 | Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. N Gren [Finlande] ; J. Bergman [Finlande] ; U. Ruotsalainen [Finlande] | PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease |
005D60 | Rinne [Finlande] | Nigral degeneration in parkinson's disease |
005E67 | J. O. Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. Nagren ; J. Bergman ; U. Ruotsalainen | PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease |
005E70 | J. O. Rinne [Finlande] | Nigral degeneration in Parkinson's disease |
006025 | Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse] | Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease |
006286 | Rinne [Finlande] ; A. Laihinen [Finlande] ; J. O. Rinne [Finlande] ; K. Na Gren [Finlande] ; J. Bergman [Finlande] ; U. Ruotsalainen [Finlande] | Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease |
006409 | U K Rinne [Finlande] | Early dopamine agonist therapy in Parkinson's disease. |
006461 | Rinne [Finlande] | Early dopamine agonist therapy in Parkinson's disease |
006688 | Calne [Canada] ; Urpo K. Rinne [Finlande] | Controversies in the management of Parkinson's disease |
This area was generated with Dilib version V0.6.23. |